Whether you're seeking medical advice, a prescription or care, immediate access to expert primary care is just a button away
The medication is administered with a very small, thin needle designed to go just under the skin, not deep into a muscle
Clinical trials in the STEP programme demonstrate average weight loss of 1015% of body weight over 68 weeks with semaglutide, primarily through decreased food consumption rather than metabolic acceleration
Victoza is FDA-approved for two indications: To improve blood sugar control in adults and children aged 10 and older with type 2 diabetes To reduce cardiovascular risk in adults with type 2 diabetes and heart disease Saxenda is FDA-approved for weight loss in the following populations: Adults with obesity (body mass index, or BMI, of 30 or higher) Adults with overweight (BMI of 27 or higher) and a weight-related health condition, such as high blood pressure or cholesterol Children aged 12 and older with obesity The FDA approved a generic version of Victoza , known simply as liraglutide , in late 2024
Specifically, improvement of overall CV outcomes was likely driven by reduction in HF-related events in trials investigating SGLT2 inhibitors, and by reduction in atherosclerotic events in those investigating GLP-1RAs
Youre at greater risk of pancreatitis if you: have obesity are over 70 are a smoker have two or more alcoholic drinks a day have a family history of the condition Gallbladder problems Gallbladder problems are a rare side effect of Mounjaro